Association of serum homocysteine with vitamin B12 and folate levels in women with pre-eclampsia in a tertiary health care center in Nepal.
Homocysteine
Hypertension
Pre-eclampsia
Pregnancy
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
09 Aug 2024
09 Aug 2024
Historique:
received:
25
09
2023
accepted:
29
07
2024
medline:
10
8
2024
pubmed:
10
8
2024
entrez:
9
8
2024
Statut:
epublish
Résumé
Pre-eclampsia is a syndrome that chiefly includes the development of new-onset hypertension and proteinuria after 20 weeks of pregnancy. Pre-eclampsia is one of the major causes of mortality and morbidity in Nepal. Hyperhomocysteinemia may be a cause of the endothelial dysfunction provoked by oxidative stress in pre-eclampsia. This study was designed to evaluate the association of homocysteine with Vitamin B12 and folate in patients with pre-eclampsia. An observational cross sectional study was performed in the Gynecology and Obstetrics Department of TUTH involving seventy two subjects with pre-eclampsia. Blood pressure, urinary protein levels, serum homocysteine, Vitamin B12 and folate levels were compared in both mild and severe forms of pre-eclampsia. Concentration of Vitamin B12 and folate were measured using Vitros ECI and homocysteine was measured using CLIA. SPSS 23.0 was used to analyze the data. Tests were performed with Mann Whitney Test and Spearman's rank correlation test. A p-value < 0.05 was considered statistically significant. This study showed no significant difference in age and weeks of gestation in both mild and severe forms of pre-eclampsia. Mean concentration of homocysteine was higher (13.1 ± 6.4 micromol/L) in severe Pre-eclampsia as compared to mild cases (7.6 ± 2.8 micromol/L). Mean concentration of folate was lower in severe cases (35.4 ± 24.1 micromol/L) when compared with mild cases of pre-eclampsia (57 ± 23.4 micromol/L). Homocysteine levels were increased in severe Pre-eclampsia when compared with mild pre-eclampsia and this finding can be used to predict and prevent complications in patients with pre-eclampsia.
Sections du résumé
BACKGROUND
BACKGROUND
Pre-eclampsia is a syndrome that chiefly includes the development of new-onset hypertension and proteinuria after 20 weeks of pregnancy. Pre-eclampsia is one of the major causes of mortality and morbidity in Nepal. Hyperhomocysteinemia may be a cause of the endothelial dysfunction provoked by oxidative stress in pre-eclampsia. This study was designed to evaluate the association of homocysteine with Vitamin B12 and folate in patients with pre-eclampsia.
METHOD
METHODS
An observational cross sectional study was performed in the Gynecology and Obstetrics Department of TUTH involving seventy two subjects with pre-eclampsia. Blood pressure, urinary protein levels, serum homocysteine, Vitamin B12 and folate levels were compared in both mild and severe forms of pre-eclampsia. Concentration of Vitamin B12 and folate were measured using Vitros ECI and homocysteine was measured using CLIA. SPSS 23.0 was used to analyze the data. Tests were performed with Mann Whitney Test and Spearman's rank correlation test. A p-value < 0.05 was considered statistically significant.
RESULTS
RESULTS
This study showed no significant difference in age and weeks of gestation in both mild and severe forms of pre-eclampsia. Mean concentration of homocysteine was higher (13.1 ± 6.4 micromol/L) in severe Pre-eclampsia as compared to mild cases (7.6 ± 2.8 micromol/L). Mean concentration of folate was lower in severe cases (35.4 ± 24.1 micromol/L) when compared with mild cases of pre-eclampsia (57 ± 23.4 micromol/L).
CONCLUSION
CONCLUSIONS
Homocysteine levels were increased in severe Pre-eclampsia when compared with mild pre-eclampsia and this finding can be used to predict and prevent complications in patients with pre-eclampsia.
Identifiants
pubmed: 39123143
doi: 10.1186/s12905-024-03284-9
pii: 10.1186/s12905-024-03284-9
doi:
Substances chimiques
Homocysteine
0LVT1QZ0BA
Folic Acid
935E97BOY8
Vitamin B 12
P6YC3EG204
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
451Informations de copyright
© 2024. The Author(s).
Références
Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237–60.
doi: 10.1097/AOG.0000000000003891
Payne B, Magee LA, von Dadelszen P. Assessment, surveillance and prognosis in pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):449–62.
doi: 10.1016/j.bpobgyn.2011.02.003
pubmed: 21459048
Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ. 2010;341:c2207.
doi: 10.1136/bmj.c2207
pubmed: 20739360
Roberts JM, Pearson GD, Cutler JA, Lindheimer MD, National Heart L, Blood I. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertens Pregnancy. 2003;22(2):109–27.
doi: 10.1081/PRG-120016792
pubmed: 12908996
Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J Pregnancy. 2011;2011:481095.
doi: 10.1155/2011/481095
pubmed: 21547090
pmcid: 3087154
Manandhar BL, Geater CV. Antenatal Care and severe pre-eclampsia in Kathmandu valley. J Chitwan Med Coll. 2013;3(6):43–7.
Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. J Pregnancy. 2012;2012:586578.
doi: 10.1155/2012/586578
pubmed: 22848831
pmcid: 3403177
Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H. A brief overview of preeclampsia. J Clin Med Res. 2014;6(1):1–7.
pubmed: 24400024
Kharb S, Aggarwal D, Bala J, Nanda S. Evaluation of homocysteine, vitamin B12 and folic acid levels during all the trimesters in pregnant and Preeclamptic Womens. Curr Hypertens Rev. 2016;12(3):234–8.
doi: 10.2174/1573402112666161010151632
pubmed: 27748186
Acilmis YG, Dikensoy E, Kutlar AI, Balat O, Cebesoy FB, Ozturk E, et al. Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre-eclampsia. J Obstet Gynaecol Res. 2011;37(1):45–50.
doi: 10.1111/j.1447-0756.2010.01317.x
pubmed: 21040211
Fenech M. Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity. Mutat Res. 2012;733(1–2):21–33.
doi: 10.1016/j.mrfmmm.2011.11.003
pubmed: 22093367
Wadhwani NS, Patil VV, Mehendale SS, Wagh GN, Gupte SA, Joshi SR. Increased homocysteine levels exist in women with preeclampsia from early pregnancy. J Matern Fetal Neonatal Med. 2016;29(16):2719–25.
pubmed: 26552939
Steegers-Theunissen RP, Steegers EA. Nutrient-gene interactions in early pregnancy: a vascular hypothesis. Eur J Obstet Gynecol Reprod Biol. 2003;106(2):115–7.
doi: 10.1016/S0301-2115(02)00358-5
pubmed: 12551774
Shih CC, Shih YL, Chen JY. The association between homocysteine levels and cardiovascular disease risk among middle-aged and elderly adults in Taiwan. BMC Cardiovasc Disord. 2021;21(1):191.
doi: 10.1186/s12872-021-02000-x
pubmed: 33879044
pmcid: 8056530
Dodds L, Fell DB, Dooley KC, Armson BA, Allen AC, Nassar BA, et al. Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. Clin Chem. 2008;54(2):326–34.
doi: 10.1373/clinchem.2007.097469
pubmed: 18070815
Chaudhry SH, Taljaard M, MacFarlane AJ, Gaudet LM, Smith GN, Rodger M, et al. The role of maternal homocysteine concentration in placenta-mediated complications: findings from the Ottawa and Kingston birth cohort. BMC Pregnancy Childbirth. 2019;19(1):75.
doi: 10.1186/s12884-019-2219-5
pubmed: 30782144
pmcid: 6381683
Gynecologists ACoOa. Hypertension in pregnancy. Report of the American College of Obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122.
Rajkovic A, Mahomed K, Malinow MR, Sorenson TK, Woelk GB, Williams MA. Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum. Obstet Gynecol. 1999;94(3):355–60.
pubmed: 10472859
Bergen NE, Jaddoe VW, Timmermans S, Hofman A, Lindemans J, Russcher H, et al. Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study. BJOG. 2012;119(6):739–51.
doi: 10.1111/j.1471-0528.2012.03321.x
pubmed: 22489763
Braekke K, Ueland PM, Harsem NK, Karlsen A, Blomhoff R, Staff AC. Homocysteine, cysteine, and related metabolites in maternal and fetal plasma in preeclampsia. Pediatr Res. 2007;62(3):319–24.
doi: 10.1203/PDR.0b013e318123fba2
pubmed: 17622947
Hague WM. Homocysteine and pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003;17(3):459–69.
doi: 10.1016/S1521-6934(03)00009-9
pubmed: 12787538
Herrmann W, Hubner U, Koch I, Obeid R, Retzke U, Geisel J. Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency. Clin Chem Lab Med. 2004;42(10):1109–16.
doi: 10.1515/CCLM.2004.228
pubmed: 15552268
Wang J, Trudinger BJ, Duarte N, Wilcken DE, Wang XL. Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia. BJOG. 2000;107(7):935–8.
doi: 10.1111/j.1471-0528.2000.tb11095.x
pubmed: 10901568
Mujawar SA, Patil VW, Daver RG. Study of serum homocysteine, folic acid and vitamin b(12) in patients with preeclampsia. Indian J Clin Biochem. 2011;26(3):257–60.
doi: 10.1007/s12291-011-0109-3
pubmed: 22754189
pmcid: 3162959
Salehi-Pourmehr H, Mohamad-Alizadeh S, Malakouti J, Farshbaf-Khalili A. Association of the folic acid consumption and its serum levels with preeclampsia in pregnant women. Iran J Nurs Midwifery Res. 2012;17(6):461–6.
pubmed: 23922590
pmcid: 3733294
Patrick TE, Powers RW, Daftary AR, Ness RB, Roberts JM. Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension. 2004;43(6):1279–82.
doi: 10.1161/01.HYP.0000126580.81230.da
pubmed: 15096466
Sanchez SE, Zhang C, Rene Malinow M, Ware-Jauregui S, Larrabure G, Williams MA. Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol. 2001;153(5):474–80.
doi: 10.1093/aje/153.5.474
pubmed: 11226979
Also-Rallo E, Lopez-Quesada E, Urreizti R, Vilaseca MA, Lailla JM, Balcells S, et al. Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol. 2005;120(1):45–52.
doi: 10.1016/j.ejogrb.2004.08.008
pubmed: 15866085
Lopez-Quesada E, Vilaseca MA, Lailla JM. Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2003;108(1):45–9.
doi: 10.1016/S0301-2115(02)00367-6
pubmed: 12694969
Powers RW, Dunbar MS, Gallaher MJ, Roberts JM. The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy. Obstet Gynecol. 2003;101(4):762–6.
pubmed: 12681883
Mignini LE, Latthe PM, Villar J, Kilby MD, Carroli G, Khan KS. Mapping the theories of preeclampsia: the role of homocysteine. Obstet Gynecol. 2005;105(2):411–25.
doi: 10.1097/01.AOG.0000151117.52952.b6
pubmed: 15684173
Yanez P, Vasquez CJ, Rodas L, Duran A, Chedraui P, Liem KH, et al. Erythrocyte folate content and serum folic acid and homocysteine levels in preeclamptic primigravidae teenagers living at high altitude. Arch Gynecol Obstet. 2013;288(5):1011–5.
doi: 10.1007/s00404-013-2851-7
pubmed: 23609037
Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr. 1998;157(Suppl 2):S40–4.
doi: 10.1007/PL00014300
pubmed: 9587024
Mangge H, Becker K, Fuchs D, Gostner JM. Antioxidants, inflammation and cardiovascular disease. World J Cardiol. 2014;6(6):462–77.
doi: 10.4330/wjc.v6.i6.462
pubmed: 24976919
pmcid: 4072837